HealthEquity (NASDAQ:HQY) Director Gayle Furgurson Wellborn Sells 2,439 Shares

HealthEquity, Inc. (NASDAQ:HQY) Director Gayle Furgurson Wellborn sold 2,439 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $219,510.00. Following the completion of the sale, the director directly owned 19,733 shares in the company, valued at $1,775,970. This represents a 11.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

HealthEquity Trading Up 3.0%

Shares of HQY traded up $2.65 during mid-day trading on Monday, hitting $90.64. The company had a trading volume of 1,399,147 shares, compared to its average volume of 1,017,490. The business’s 50-day simple moving average is $83.44 and its 200-day simple moving average is $86.67. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $116.65. The stock has a market cap of $7.58 billion, a PE ratio of 33.95, a P/E/G ratio of 1.60 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last released its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The business had revenue of $354.64 million for the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Sell-side analysts forecast that HealthEquity, Inc. will post 3.84 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of HQY. William Blair Investment Management LLC acquired a new position in HealthEquity during the fourth quarter valued at approximately $169,956,000. Norges Bank acquired a new position in shares of HealthEquity during the fourth quarter worth $66,927,000. AQR Capital Management LLC lifted its position in shares of HealthEquity by 148.5% during the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after purchasing an additional 661,795 shares in the last quarter. Wasatch Advisors LP lifted its position in shares of HealthEquity by 9.3% during the first quarter. Wasatch Advisors LP now owns 7,202,934 shares of the company’s stock worth $601,949,000 after purchasing an additional 613,288 shares in the last quarter. Finally, Millennium Management LLC lifted its position in shares of HealthEquity by 151.5% during the fourth quarter. Millennium Management LLC now owns 951,563 shares of the company’s stock worth $87,173,000 after purchasing an additional 573,283 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on HQY. Wells Fargo & Company set a $111.00 target price on shares of HealthEquity in a research report on Monday. Deutsche Bank Aktiengesellschaft raised their target price on shares of HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a research report on Thursday, March 19th. KeyCorp reissued an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a research report on Monday. Finally, BMO Capital Markets raised shares of HealthEquity from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $85.00 to $105.00 in a research report on Thursday, April 9th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and an average target price of $111.53.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.